Cytori Therapeutics (CYTX) Tops Q3 EPS by 3c

Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold